Hot Products
Catalog No. | Information |
CFN97438 | 11(13)-Dehydroivaxillin 11(13)-Dehydroivaxillin possesses a promising antiplasmodial activity, which can be exploited in malaria therapy. |
CFN89426 | 11-Anhydro-16-oxoalisol A Reference standards. |
CFN90052 | 11Beta-hydroxyprogesterone The progesterone derivatives 11 alpha- and 11 beta-hydroxyprogesterone are potent inhibitors of 11 beta-hydroxysteroid dehydrogenase (isoforms 1 and 2) in vitro and can confer mineralocorticoid activity on corticosterone in the rat in vivo. 11beta-Hydroxyprogesterone acts as a mineralocorticoid agonist in stimulating Na+ absorption in mammalian principal cortical collecting duct cells. |
CFN92401 | 11-Deoxyalisol B Reference standards. |
CFN92125 | 11-Hydroxycanthin-6-one 11-Hydroxy-canthin-6-one has antineoplastic activity. |
CFN97887 | 11-Hydroxygelsenicine Standard reference |
CFN90366 | 11-Hydroxy-sugiol Reference standards. |
CFN98205 | 11-Hydroxytabersonine 11-Hydroxytabersonine has antitumor activety. |
CFN90152 | 11-Keto-beta-boswellic acid 11-Keto-beta-boswellic acid, a novel Nrf2 activator, and a selective 5-lipoxygenase (5-LOX) inhibitor; it exerts dose dependent cardioprotective effect manifested by dose-dependent reduction in serum lactate dehydrogenase; and it can increase the Nrf2 and HO-1 expression, which provides protection against oxygen and glucose deprivation (OGD)-induced oxidative insult. 11-Keto-beta-boswellic acid possesses significant anti-inflammatory, and anti-tumoral activities. |
CFN96345 | 11-O-Galloylbergenin 11-O-Galloylbergenin shows good antioxidant and antiplasmodial activities, it shows significant analgesic activity at doses of 20 and 40 mg/kg against formalin test in rats, and it exhibits significant anti-inflammatory activity in carrageenan-induced paw edema model at doses of 10, 20 and 30 mg/kg.11-O-Galloylbergenin shows significant urease inhibitory potential with IC50 value of 38.6±1.5 uM. |